Company News | September 16, 2026 Antagen Biosciences Expands Recombinant Protein Expression Platforms to Support Global Biopharma Research
Company News | September 16, 2026 Innovations in Glyco-Engineered Cell LinesEnhancing ADCC Activity and Efficacy for Targeted Immunotherapy
Company News | September 16, 2026 Advances in Rapid Monoclonal Antibody Isotyping for Next-Generation Biologics